The inspector general at the U.S. Department of Health and Human Services could launch an inquiry into the scientist, UT child pharmacology researcher Karen Wagner. Iowa Sen. Charles Grassley, the ranking member of the Senate Finance Committee, sent a letter to the University of Texas System in September raising concerns that Karen Wagner had not properly disclosed her financial connections with drug companies.
Read article in the Dallas Morning News (USA)
Monday, May 25, 2009
University of Texas System Researcher's Ties to Drug Firms Questioned
Subscribe to:
var sc_project=1725605;
var sc_invisible=0;
var sc_partition=16;
var sc_security="acf71b9a";